Newsletter on the Edinburgh University website:
https://www.ed.ac.uk/inflammation-research/news-events/the-9th-european-workshop-on-lipid-mediators

Thursday (19:30) Gala dinner will take place in the South Hall at Pollock Estate, followed by a Scottish Ceilidh (remember to wear proper shoes for dancing) and a drink bar (for bank cards only)

____________________________________________________________________

8EWLM - Prostaglandin and Other Lipid Mediators Special Issue

• DHA, RvD1, RvD5, and MaR1 reduce human coronary arteries contractions induced by PGE2. Amel Bouhadoun, Hasanga D. Manikpurage, Catherine Deschildre, Sara Zalghout, ... Xavier Norel.
• Resolvins and cysteinyl-containing pro-resolving mediators activate resolution of infectious inflammation and tissue regeneration. Charles N. Serhan, Nan Chiang.
• Formation of lipoxins and resolvins in human leukocytes. Astrid S. Kahnt, Nils Helge Schebb, Dieter Steinhilber.
• Microsomal prostaglandin E synthase-1 inhibition promotes shunting in arachidonic acid metabolism during inflammatory responses in vitro. Jianyang Liu, Bing Peng, Julia Steinmetz-Späh, Helena Idborg, ... Per-Johan Jakobsson.
• Cisplatin and progesterone separate and combined action on rat brain nuclear phospholipids content. N.R. Hakobyan, ZH.V. Yavroyan, A.G. Hovhannisyan, E.S. Gevorgyan.
• Sphingolipidoses in Morocco: Chemical profiling for an affordable and rapid diagnosis strategy. M. Hammoud, A.M.S. Rodrigues, I. Assiri, Es Sabir, ... N. Fdil.
• Cross-talk between bioactive lipid mediators and the unfolded protein response in ischemic stroke. Tarvi Teder, Jesper Z. Haeggström, Mikko Airavaara, Helike Lõhelaid.
• Defining the contractile prostanoid component in hyperosmolar-induced bronchoconstriction in human small airways. Maria Belikova, Mamdoh Al-Ameri, Ann-Charlotte Orre, Jesper Säfholm.
• Specialized pro-resolving lipid mediators and resolution of viral diseases. Giulia Ferri, Matteo Mucci, Domenico Mattoscio, Antonio Recchiuti.
• Set up and validation of a sensitive method to quantify prostaglandins, prostaglandin-glycerol esters and prostaglandin-ethanolamides, as well as their respective precursors. Adrien Paquot, Juan Bestard-Escalas, Giulio G. Muccioli.
• The effect of SARS-CoV-2 variants on the plasma oxylipins and PUFAs of COVID-19 patients. Denise Biagini, Paolo Oliveri, Andreina Baj, Daniela Dalla Gasperina, ... Fabio Di Francesco.
• Binding interactions of fatty acyl lipid mediators within the vanilloid pocket of TRPV1: A molecular dynamics study. Nada Birkic, David Visentin, Željko Svedružić, Christian A. Reynolds.
• A single extraction 96-well method for LC-MS/MS quantification of urinary eicosanoids, steroids and drugs. Julia Sieminska, Johan Kolmert, Javier Zurita, Kurt Benkestock, ... Craig E. Wheelock.
• Oxylipin profiling by LC-ESI-MS/MS in canine serum and plasma to investigate ovulation-specific changes. Margareta Ramström, Bodil S. Holst, Richard Lindberg, Malin L. Nording.
• Editorial – Special issue of the 8th European Workshop on Lipid Mediators. Giulio G. Muccioli, Gerard Bannenberg.

____________________________________________________________________

The Global Organization for EPA and DHA Omega-3s (GOED) has been building a comprehensive, searchable database of all interventional human studies on EPA and DHA — almost 4,000 studies! The Clinical Study Database has been completed and includes two different sections:

Abstract Search: Includes details on whether the studies are positive, negative or neutral (according to abstract outcomes), plus associated keywords, influential study authors and relevant journals.

Advanced Search: Includes data on every outcome from a given study, is fully searchable and can be filtered by variables.
Have a look

Two open PhD positions (Biology or Analytical Chemistry) in the group of Prof. Dr. Schebb - Faculty of Mathematics and Natural Sciences, University of Wuppertal, Germany. LINK to APPLY

• One PhD aims to develop and apply liquid new chromatography (LC) and gas chromatography (GC) methods coupled to MS for the characterization and quantification of lipids and other cellular metabolites. Both targeted as well as non-targeted metabolomics are applied to evaluate the effects of diet food ingredients.
• 
  A second PhD project aims to aims to employ human primary cell culture of leucocytes (neutrophils, monocyte-derived macrophages) to evaluate the (anti)-inflammatory effects of food ingredients. Biological endpoints such as phagocytosis and cytokine release are correlated with the levels of lipids and other cellular metabolites.

New PhD position
Call for applications 2022